Filter
543
Filtered Results: 543
Text search:
COVID-19
and
pregnancy
Featured
Recommendations
73
New Publications
18
Language
Document type
Studies & Reports
198
Guidelines
164
Strategic & Response Plan
51
Fact sheets
47
Manuals
40
Situation Updates
13
Training Material
10
Infographics
7
No document type
6
Resource Platforms
3
Videos
2
Brochures
1
App
1
Countries / Regions
Global
58
India
20
Latin America and the Carribbean
18
South Africa
16
Brazil
14
Western and Central Europe
12
Russia
11
Ukraine
10
Syria
9
Kenya
9
Nigeria
8
East and Southern Africa
8
Middle East and North Africa
8
South–East Asia Region
8
Bangladesh
6
Malawi
6
Eastern Europe and Central Asia
6
Yemen
5
Africa
5
Congo, Democratic Republic of
4
Ethiopia
4
Haiti
4
Zambia
4
Western Pacific Region
4
Philippines
3
Nepal
3
South Sudan
3
Afghanistan
3
Germany
3
Colombia
3
West and Central Africa
3
Venezuela
3
Ghana
2
Uganda
2
Somalia
2
Lebanon
2
Mozambique
2
Argentina
2
Peru
2
Ecuador
2
Bolivia
2
Myanmar / Burma
2
Palestine
2
Laos
2
North America
2
Sierra Leone
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Cameroon
1
Zimbabwe
1
Pakistan
1
Turkey
1
Cambodia
1
Thailand
1
Rwanda
1
Indonesia
1
Sudan
1
Central African Republic
1
Namibia
1
Eswatini/ Swaziland
1
Honduras
1
Botswana
1
Sri Lanka
1
Chile
1
Asia
1
Fiji
1
Eastern Europe
1
Congo-Brazzaville
1
Bulgaria
1
Vietnam
1
Jamaica
1
France
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
200
Women & Child Health
52
Clinical Guidelines
46
Public Health
38
Capacity Building
10
Key Resources
9
Pharmacy & Technologies
4
Toolboxes
COVID-19
254
HIV
42
Caregiver
30
NCDs
24
Mental Health
19
Conflict
16
Planetary Health
14
Refugee
12
Rapid Response
10
TB
10
Global Health Education
10
Pharmacy
10
Natural Hazards
8
NTDs
6
Health Financing Toolbox
5
AMR
3
Disability
2
Zika
2
Cholera
1
abridged version, March 2021
he study highlights the impacts of COVID-19 on women and men as gleaned from research conducted during 2020, as well ...
This guidance note aims to provide practical support to service providers operating Women and Girls Safe Spaces (WGSS) on how to adapt programming in the context of the COVID-... pandemic.
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 ha...
The COVID-19 pandemic has exacerbated and added yet another layer of vulnerability to an already dire web of vulnerabilities of girls in the Africa...
It estimates that there have been 228,000 additional deaths of children under five in these six countries [Afghanistan, Nepal, Bangladesh, India, Pakistan and Sri Lanka] due to crucial services, ranging from nutrition benefits to immunisation, being...
In the wake of the Covid‑19 Pandemic, parts of the public health system at increased risk of reduced efficiency include healthcare services for women and children. This in turn could reverse all the progress achieved over the ye...
RESULTS: Between 76 and 97% of the PHCS offered RMCAH services before the lockdown. Except in antenatal, delivery and adolescent care, there was a decline of between 2 ... 6% in all the services during the lockdown and up to 10% decline after the lockdown with variation across and within States. During the lockdown. Full-service delivery was reported by 75.2% whereas 24.8% delivered partial services. There was a significant reduction in clients' utilization of the services during the lockdown, and the difference between States before the pandemic, during, and after the lockdown. Reported difficulties during the lockdown included stock-out of drugs (25.7%), stock-out of contraceptives (25.1%), harassment by the law enforcement agents (76.9%), and transportation difficulties (55.8%). Only 2% of the PHCs reported the availability of gowns, 18% had gloves, 90.1% had hand sanitizers, and a temperature checker was available in 94.1%. Slightly above 10% identified clients with symptoms of COVID-19.
CONCLUSIONS: The large proportion of PHCs who provided RMCAH services despite the lockdown demonstrates resilience. Considering the several difficulties reported, and the limited provision of primary protective equipment more effort by the government and non-governmental agencies is recommended to strengthen delivery of sexual and reproductive health in primary health centres in Nigeria during the pandemic.
14 January 2021
This practical guide can be used to help countries monitor and analyse the impact of COVID-19 on essential health services to info...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns ...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-.... This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
Brazil ́s response is taking place in strict compliance with the International Health Regulations (IHR) 2005.
Brazil created the Emergency Operations Center (COE) and immediately notified WHO when the first case in Brazilian territory
was confirm...
This topic last updated: Apr 28, 2020.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or condi...
Practical considerations
It provides more detailed and practical guidance for continuing services for each life stage across the life-course continuum. As such, both documents should be read and us...
COVID-19 infection affects all age groups including newborns, however, literature is scarce on the fetal and neonatal outcomes of babies e...
Q&A on COVID-19, HIV and antiretrovirals - Hỏi Đáp về COVID-..., HIV và thuốc antiretrovirals (ARVs)
The COVID-19 pandemic is having far reaching impacts, well beyond the health crisis and needs, with the most severe impacts experienced in the poor...
This document provides answers to FAQs healthcare providers and staff may have about COVID-19 vaccines
The COVID-19 Strategic Preparedness and Response Plan (SPRP) 2021 Monitoring and Evaluation Fram...
